AVAH SEC Filing News — Aveanna Healthcare Holdings Inc.

Latest SEC filings for Aveanna Healthcare Holdings Inc. (AVAH) explained in plain English. Covers insider buying and selling (Form 4), proposed insider sales (Form 144), material company events (8-K), and quarterly & annual reports (10-Q / 10-K). StrongBuyAnalytics provides navigation and brief excerpts or summaries; original filings remain at the SEC/source links and were authored by their filers, not StrongBuyAnalytics. Filing dates shown are source dates. Coverage and detection can be delayed or incomplete because of SEC availability, amendments, parsing, caching, or outages. Latest source filing date shown: 2026-10-05.

Aveanna Healthcare Holdings Inc., a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities. The company operates through three segments: Private Duty Services (PDS), Home Health & Hospice (HHH), and Medical Solutions (MS). The PDS segment offers pri…
Sector: Healthcare Industry: Medical Care Facilities Market Cap: $2.7B CIK: 1832332
20
Total Filings
0
Bullish Classifications
9
Bearish Classifications
10
Insider Transactions
5
Material Events (8-K)
1
Periodic Reports
Rule-based classifications for AVAH currently lean bearish. Of the 20 filing records displayed, 9 carry bearish classifications (such as insider sales or negative 8-K disclosures) versus 0 bullish. This does not necessarily signal fundamental deterioration — insiders sell for many reasons — but it is worth monitoring alongside the company's core financial metrics.
AVAH Filing Activity Snapshot 2026-06-30 — 2026-10-05
Insider Transactions (Form 4)
0 buys vs 9 sells
Net insider selling in this period — insiders sell for many reasons beyond conviction.
Largest Form 144 Filing
$192.63M
WILLIAMS ROBERT M JR (10% Owner) · 2026-08-24
16,750,002 shares · Form 4
Form 144 Notices
4
Proposed insider sales filed — Form 144 is a notice of intent, not a confirmed transaction. Actual sales are confirmed via Form 4.
Insider Transactions 10 · Forms 3, 4 and 5

A Form 4 is filed within two business days of a company insider — an officer, a director, or a holder of more than ten percent of the stock — changing their position in the shares. All 10 filings in this group are Form 4s for Aveanna Healthcare Holdings Inc.

The difficulty with reading these filings as a group is that a single form type covers transactions that mean entirely different things. An executive spending their own money to buy stock and an executive having shares withheld to pay tax on a vesting grant both appear as a Form 4. Every filing below is therefore tagged with the nature of the underlying transaction, taken from the transaction code reported on the form itself.

Across the 10 insider filings shown, the breakdown is 9 open-market sale and 1 compensation award. 9 of them involved a discretionary open-market trade; the rest are compensation and administrative mechanics.

What each transaction type means

Open-market sale ×9
The insider sold shares on the open market. Sales may be discretionary or executed automatically under a pre-arranged Rule 10b5-1 trading plan, and a Form 4 does not always make clear which applies.
Compensation award ×1
Shares were granted as compensation rather than purchased. No cash changed hands, so the filing reflects a pay decision by the company, not a judgement about the price.
Form 4 Compensation award Tax / Compensation Filing 2026-10-05

AVAH insider Form 4 filed for equity award, exercise, or tax withholding

Stewart Deborah (SVP, Chief Accounting Officer) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

Shares were granted as compensation rather than purchased. No cash changed hands, so the filing reflects a pay decision by the company, not a judgement about the price.

Transactions reported on this filing
Code Nature Shares Price Value
A Compensation award 75,000 — —
Filing: Form 4 (Insider Transaction) Insider: Stewart Deborah (SVP, Chief Accounting Officer) Shares: 75,000
View on SEC EDGAR → Open Filing Document →
Form 4 Open-market sale Insider Selling 2026-08-24

AVAH insider J.H. Whitney Equity Partners VII, LLC (10% Owner) sold 14,746,077 shares (~$169.58M)

J.H. Whitney Equity Partners VII, LLC, listed as 10% Owner at Aveanna Healthcare Holdings, Inc., reported an open-market sale of 14,746,077 AVAH shares in a Form 4 filing. This is a confirmed insider sale, not just a proposed sale notice.

The insider sold shares on the open market. Sales may be discretionary or executed automatically under a pre-arranged Rule 10b5-1 trading plan, and a Form 4 does not always make clear which applies.

Transactions reported on this filing
Code Nature Shares Price Value
S Open-market sale 10,112,125 $11.50 $116.29M
S Open-market sale 957,918 $11.50 $11.02M
S Open-market sale 1,426,034 $11.50 $16.40M
S Open-market sale 2,250,000 $11.50 $25.88M
Filing: Form 4 (Insider Transaction) Insider: J.H. Whitney Equity Partners VII, LLC (10% Owner) Shares: 14,746,077 Est. Value: $169.58M
View on SEC EDGAR → Open Filing Document →
Form 4 Open-market sale Insider Selling 2026-08-24

AVAH insider WILLIAMS ROBERT M JR (10% Owner) sold 16,750,002 shares (~$192.63M)

WILLIAMS ROBERT M JR, listed as 10% Owner at Aveanna Healthcare Holdings, Inc., reported an open-market sale of 16,750,002 AVAH shares in a Form 4 filing. This is a confirmed insider sale, not just a proposed sale notice.

The insider sold shares on the open market. Sales may be discretionary or executed automatically under a pre-arranged Rule 10b5-1 trading plan, and a Form 4 does not always make clear which applies.

Transactions reported on this filing
Code Nature Shares Price Value
S Open-market sale 10,112,125 $11.50 $116.29M
S Open-market sale 957,918 $11.50 $11.02M
S Open-market sale 1,813,795 $11.50 $20.86M
S Open-market sale 1,426,034 $11.50 $16.40M
S Open-market sale 190,130 $11.50 $2.19M
S Open-market sale 2,250,000 $11.50 $25.88M
Filing: Form 4 (Insider Transaction) Insider: WILLIAMS ROBERT M JR (10% Owner) Shares: 16,750,002 Est. Value: $192.63M
View on SEC EDGAR → Open Filing Document →
Form 4 Open-market sale Insider Selling 2026-08-24

AVAH insider VIGANO PAUL R (10% Owner) sold 16,750,002 shares (~$192.63M)

VIGANO PAUL R, listed as 10% Owner at Aveanna Healthcare Holdings, Inc., reported an open-market sale of 16,750,002 AVAH shares in a Form 4 filing. This is a confirmed insider sale, not just a proposed sale notice.

The insider sold shares on the open market. Sales may be discretionary or executed automatically under a pre-arranged Rule 10b5-1 trading plan, and a Form 4 does not always make clear which applies.

Transactions reported on this filing
Code Nature Shares Price Value
S Open-market sale 10,112,125 $11.50 $116.29M
S Open-market sale 957,918 $11.50 $11.02M
S Open-market sale 1,813,795 $11.50 $20.86M
S Open-market sale 1,426,034 $11.50 $16.40M
S Open-market sale 190,130 $11.50 $2.19M
S Open-market sale 2,250,000 $11.50 $25.88M
Filing: Form 4 (Insider Transaction) Insider: VIGANO PAUL R (10% Owner) Shares: 16,750,002 Est. Value: $192.63M
View on SEC EDGAR → Open Filing Document →
Form 4 Open-market sale Insider Selling 2026-08-24

AVAH insider Windley Rodney D (Director) sold 180,000 shares (~$2.07M)

Windley Rodney D, listed as Director at Aveanna Healthcare Holdings, Inc., reported an open-market sale of 180,000 AVAH shares in a Form 4 filing. This is a confirmed insider sale, not just a proposed sale notice.

The insider sold shares on the open market. Sales may be discretionary or executed automatically under a pre-arranged Rule 10b5-1 trading plan, and a Form 4 does not always make clear which applies.

Transactions reported on this filing
Code Nature Shares Price Value
S Open-market sale 180,000 $11.50 $2.07M
Filing: Form 4 (Insider Transaction) Insider: Windley Rodney D (Director) Shares: 180,000 Est. Value: $2.07M
View on SEC EDGAR → Open Filing Document →
Form 4 Open-market sale Insider Selling 2026-08-24

AVAH insider Shaner Jeff (Chief Executive Officer) sold 90,000 shares (~$1.03M)

Shaner Jeff, listed as Chief Executive Officer at Aveanna Healthcare Holdings, Inc., reported an open-market sale of 90,000 AVAH shares in a Form 4 filing. This is a confirmed insider sale, not just a proposed sale notice.

The insider sold shares on the open market. Sales may be discretionary or executed automatically under a pre-arranged Rule 10b5-1 trading plan, and a Form 4 does not always make clear which applies.

Transactions reported on this filing
Code Nature Shares Price Value
S Open-market sale 90,000 $11.50 $1.03M
Filing: Form 4 (Insider Transaction) Insider: Shaner Jeff (Chief Executive Officer) Shares: 90,000 Est. Value: $1.03M
View on SEC EDGAR → Open Filing Document →
Form 4 Open-market sale Insider Selling 2026-08-24

AVAH insider Reisz Edwin C. (Chief Administrative Officer) sold 50,000 shares (~$575.0K)

Reisz Edwin C., listed as Chief Administrative Officer at Aveanna Healthcare Holdings, Inc., reported an open-market sale of 50,000 AVAH shares in a Form 4 filing. This is a confirmed insider sale, not just a proposed sale notice.

The insider sold shares on the open market. Sales may be discretionary or executed automatically under a pre-arranged Rule 10b5-1 trading plan, and a Form 4 does not always make clear which applies.

Transactions reported on this filing
Code Nature Shares Price Value
S Open-market sale 50,000 $11.50 $575.0K
Filing: Form 4 (Insider Transaction) Insider: Reisz Edwin C. (Chief Administrative Officer) Shares: 50,000 Est. Value: $575.0K
View on SEC EDGAR → Open Filing Document →
Form 4 Open-market sale Insider Selling 2026-07-02

AVAH insider WILLIAMS ROBERT M JR (10% Owner) sold 3,000,000 shares (~$24.03M)

WILLIAMS ROBERT M JR, listed as 10% Owner at Aveanna Healthcare Holdings, Inc., reported an open-market sale of 3,000,000 AVAH shares in a Form 4 filing. This is a confirmed insider sale, not just a proposed sale notice.

The insider sold shares on the open market. Sales may be discretionary or executed automatically under a pre-arranged Rule 10b5-1 trading plan, and a Form 4 does not always make clear which applies.

Transactions reported on this filing
Code Nature Shares Price Value
S Open-market sale 2,419,035 $8.01 $19.38M
S Open-market sale 525,844 $8.01 $4.21M
S Open-market sale 55,121 $8.01 $441.5K
Filing: Form 4 (Insider Transaction) Insider: WILLIAMS ROBERT M JR (10% Owner) Shares: 3,000,000 Est. Value: $24.03M
View on SEC EDGAR → Open Filing Document →
Form 4 Open-market sale Insider Selling 2026-07-02

AVAH insider VIGANO PAUL R (10% Owner) sold 3,000,000 shares (~$24.03M)

VIGANO PAUL R, listed as 10% Owner at Aveanna Healthcare Holdings, Inc., reported an open-market sale of 3,000,000 AVAH shares in a Form 4 filing. This is a confirmed insider sale, not just a proposed sale notice.

The insider sold shares on the open market. Sales may be discretionary or executed automatically under a pre-arranged Rule 10b5-1 trading plan, and a Form 4 does not always make clear which applies.

Transactions reported on this filing
Code Nature Shares Price Value
S Open-market sale 2,419,035 $8.01 $19.38M
S Open-market sale 525,844 $8.01 $4.21M
S Open-market sale 55,121 $8.01 $441.5K
Filing: Form 4 (Insider Transaction) Insider: VIGANO PAUL R (10% Owner) Shares: 3,000,000 Est. Value: $24.03M
View on SEC EDGAR → Open Filing Document →
Form 4 Open-market sale Insider Selling 2026-07-02

AVAH insider J.H. Whitney Equity Partners VII, LLC (10% Owner) sold 2,419,035 shares (~$19.38M)

J.H. Whitney Equity Partners VII, LLC, listed as 10% Owner at Aveanna Healthcare Holdings, Inc., reported an open-market sale of 2,419,035 AVAH shares in a Form 4 filing. This is a confirmed insider sale, not just a proposed sale notice.

The insider sold shares on the open market. Sales may be discretionary or executed automatically under a pre-arranged Rule 10b5-1 trading plan, and a Form 4 does not always make clear which applies.

Transactions reported on this filing
Code Nature Shares Price Value
S Open-market sale 2,419,035 $8.01 $19.38M
Filing: Form 4 (Insider Transaction) Insider: J.H. Whitney Equity Partners VII, LLC (10% Owner) Shares: 2,419,035 Est. Value: $19.38M
View on SEC EDGAR → Open Filing Document →
Proposed Insider Sales 4 · Form 144

A Form 144 is a notice of intent to sell restricted or control securities. It is not a record that anything was sold. Aveanna Healthcare Holdings Inc. has 4 such notices in this period.

The distinction matters because a Form 144 is frequently reported as though it were a completed insider sale. The filer may sell all of the shares covered, some of them, or none at all, and there is no obligation to update the notice either way. A sale that is actually executed by an officer or director shows up separately on a Form 4, which is the filing to check before treating a proposed sale as a real one.

Form 144 Proposed Insider Sale 2026-09-09

AVAH Form 144 filed for proposed insider sale by ERICA G SCHWARTZ (46,071 shares) ~$645.0K

ERICA G SCHWARTZ filed a Form 144 with the SEC indicating intent to sell AVAH (Aveanna Healthcare Holdings, Inc.) shares. Form 144 reflects a proposed sale, not a completed transaction. The actual execution, if any, would typically appear later in a Form 4.

Filing: Form 144 (Proposed Sale Notice) Insider: ERICA G SCHWARTZ Shares: 46,071 Est. Value: $645.0K
View on SEC EDGAR → Open Filing Document →
Form 144 Proposed Insider Sale 2026-08-27

AVAH Form 144 filed for proposed insider sale by ERICA G SCHWARTZ (230,343 shares) ~$3.22M

ERICA G SCHWARTZ filed a Form 144 with the SEC indicating intent to sell AVAH (Aveanna Healthcare Holdings, Inc.) shares. Form 144 reflects a proposed sale, not a completed transaction. The actual execution, if any, would typically appear later in a Form 4.

Filing: Form 144 (Proposed Sale Notice) Insider: ERICA G SCHWARTZ Shares: 230,343 Est. Value: $3.22M
View on SEC EDGAR → Open Filing Document →
Form 144 Proposed Insider Sale 2026-06-30

AVAH Form 144 filed for proposed insider sale by JHW Iliad Holdings II LLC (55,121 shares) ~$472.4K

JHW Iliad Holdings II LLC filed a Form 144 with the SEC indicating intent to sell AVAH (Aveanna Healthcare Holdings, Inc.) shares. Form 144 reflects a proposed sale, not a completed transaction. The actual execution, if any, would typically appear later in a Form 4.

Filing: Form 144 (Proposed Sale Notice) Insider: JHW Iliad Holdings II LLC Shares: 55,121 Est. Value: $472.4K
View on SEC EDGAR → Open Filing Document →
Form 144 Proposed Insider Sale 2026-06-30

AVAH Form 144 filed for proposed insider sale by JHW Iliad Holdings LLC (525,844 shares) ~$4.51M

JHW Iliad Holdings LLC filed a Form 144 with the SEC indicating intent to sell AVAH (Aveanna Healthcare Holdings, Inc.) shares. Form 144 reflects a proposed sale, not a completed transaction. The actual execution, if any, would typically appear later in a Form 4.

Filing: Form 144 (Proposed Sale Notice) Insider: JHW Iliad Holdings LLC Shares: 525,844 Est. Value: $4.51M
View on SEC EDGAR → Open Filing Document →
Material Events 5 · Form 8-K

An 8-K reports a material event in the window between scheduled reports. There are 5 in this period for Aveanna Healthcare Holdings Inc. Each 8-K names the item number it is filed under, and that number is the fastest way to tell a routine disclosure from a consequential one.

Item 2.02 is an earnings release, Item 5.02 is a change of directors or officers, and Item 1.01 or 2.01 covers a material agreement or a completed acquisition. Item 7.01 and Item 8.01 are the general-purpose disclosure items and carry no fixed meaning on their own.

Form 8-K Material Company Update 2026-10-02

AVAH filed 8-K — material company event

Aveanna Healthcare Holdings, Inc. filed an 8-K with the SEC reporting a material event. Summary unavailable — view the original SEC filing for the full text.

Filing: 8-K (Material Event)
View on SEC EDGAR → Open Filing Document →
Form 8-K Material Company Update 2026-08-24

AVAH filed 8-K — material company event

Aveanna Healthcare Holdings, Inc. filed an 8-K with the SEC reporting a material event. Summary unavailable — view the original SEC filing for the full text.

Filing: 8-K (Material Event)
View on SEC EDGAR → Open Filing Document →
Form 8-K Material Company Update 2026-08-13

AVAH filed 8-K — material company event

Aveanna Healthcare Holdings, Inc. filed an 8-K with the SEC reporting a material event. Summary unavailable — view the original SEC filing for the full text.

Filing: 8-K (Material Event)
View on SEC EDGAR → Open Filing Document →
Form 8-K Material Company Update 2026-08-13

AVAH filed 8-K — material company event

Aveanna Healthcare Holdings, Inc. filed an 8-K with the SEC reporting a material event. Summary unavailable — view the original SEC filing for the full text.

Filing: 8-K (Material Event)
View on SEC EDGAR → Open Filing Document →
Form 8-K Material Company Update 2026-08-07

AVAH filed 8-K — material company event

Aveanna Healthcare Holdings, Inc. filed an 8-K with the SEC reporting a material event. Summary unavailable — view the original SEC filing for the full text.

Filing: 8-K (Material Event)
View on SEC EDGAR → Open Filing Document →
Periodic Reports 1 · Forms 10-K and 10-Q

The periodic reports are where the audited and reviewed financial statements live. This period contains 1 quarterly report (10-Q) for Aveanna Healthcare Holdings Inc.

The two are not equivalent in weight. A 10-K is audited by an external firm and includes the full risk factor disclosure, business description and management discussion; a 10-Q is unaudited, reviewed rather than examined, and much shorter. When a figure in a quarterly report is later revised, the annual report is usually where the correction appears.

An amended report — 10-K/A or 10-Q/A — restates or corrects something in the original filing, and is worth reading against the version it replaces.

Form 10-Q Quarterly Report 2026-08-13

AVAH filed Quarterly Report (10-Q)

Aveanna Healthcare Holdings, Inc. filed its quarterly report with the SEC. This report includes unaudited financial statements and management discussion for the quarter.

Filing: 10-Q (Quarterly Report)
View on SEC EDGAR → Open Filing Document →

How we classify Aveanna Healthcare Holdings Inc.'s filings

Straight from EDGAR

Each displayed record links to an original source document. StrongBuyAnalytics provides navigation and brief excerpts or summaries, not the filing itself. Parsing may omit context or contain errors, so read the original document in full.

Transaction codes, not guesswork

The nature shown on each insider filing comes from the transaction code the filer entered on the form itself — P for an open-market purchase, A for a compensation award, F for shares withheld to pay tax, M for an option exercise. Where one filing contains several codes, the transaction table lists them line by line.

Why the distinction matters

Insider activity is routinely summarised as buying or selling, which flattens together decisions that mean very different things. Shares withheld for tax on a vesting grant are an automatic administrative step; shares bought on the open market are someone committing their own money at the current price.

What this page does not tell you

A filing records what happened, not why. Form 4 does not always disclose whether a sale was executed under a pre-arranged Rule 10b5-1 plan, and no single filing is a basis for a decision on AVAH. Read these alongside the fundamentals rather than in isolation.

Frequently Asked Questions — AVAH SEC Filings

More Tools for AVAH

AVAH Full Stock Analysis AVAH Live Chart Institutional Ownership Earnings Calendar Options Flow Scanner Semiconductor Demand Zone Tracker Sector Scanner Browse All Stocks

Want deeper AVAH analysis?

View valuation, growth metrics, the rule-based stock-page score, demand zones, peer comparison, and more — all on the AVAH stock analysis page.

AVAH Full Analysis
Publisher, sources & limitations — September 15, 2026. StrongBuyAnalytics provides navigation and brief excerpts or summaries for educational use. Original filings remain at SEC EDGAR or other displayed source links; StrongBuyAnalytics does not author them. Filing dates are source dates, not publication dates for this page. Coverage can be delayed, incomplete, amended, or unavailable because of SEC/source availability, parsing, caching, or outages. Verify every material statement in the original filing.
Data Sources · Methodology · AI Disclosure · Corrections Policy · Disclaimer